Recent Updates — ENVX
Enovix declared a special warrant dividend of approximately 65.6 million warrants to common stockholders and convertible noteholders as of the November 13, 2026 record date. Each holder receives one warrant for every four shares held. The warrants carry a $3.00 exercise price and expire on April 28, 2028, subject to early expiration if the stock reaches $3.30 VWAP for 20 of 30 days. Holders may exercise using cash or by surrendering Enovix's 3.00% Convertible Senior Notes due 2028 at face value, which would retire debt without cash outlay. The company also repurchased $100 million in 4.75% notes due 2030 at a 37% discount to par. Enovix develops and manufactures advanced lithium-ion batteries for consumer, defense, and industrial applications.
Enovix reported preliminary third-quarter 2026 revenue of $11.0 million, a 38% increase year-over-year and above the $9–$10 million guidance range. The company highlighted growth in its drone and defense pipeline, which expanded to approximately $216 million, with the drone segment alone growing 48% to $150 million. Enovix also announced a leadership realignment, promoting Steve Bakos to Chief Revenue Officer and General Manager to lead global sales and business development. The firm is investing $19 million to double capacity at its Korean manufacturing plant to support defense production. Enovix develops and manufactures advanced lithium-ion batteries for consumer electronics, smart eyewear, and defense applications.
Dr. Raj Talluri resigned as President, Chief Executive Officer, and director on August 13, 2026, to pursue another opportunity. The Board appointed T.J. Rodgers as Executive Chairman effective August 14, 2026, and named CFO Ryan Benton Interim CEO while conducting a permanent search. The company reaffirmed its third quarter 2026 financial guidance and highlighted technical progress on cycle life for smartphone batteries. Enovix Corporation develops and manufactures advanced lithium-ion batteries with proprietary silicon-anode architectures.
Enovix Corporation reported second quarter 2026 financial results on August 12, 2026. Revenue reached $9.0 million, a 21% year-over-year increase and at the high end of guidance, bringing first-half revenue to $16.6 million. The company achieved its seventh consecutive quarter of positive gross profit with a GAAP margin of 14.4%. Enovix ended the quarter with approximately $552.1 million in cash, cash equivalents, and marketable securities. Commercially, the lead smartphone customer confirmed passing more than 1,000 cycles under specific discharge tests, with final qualification testing expected to conclude in 2026. Smart eyewear shipments are ramping significantly, with approximately 19,000 packs ordered for the third quarter against a total 50,000-pack annual order. The drone and defense pipeline expanded by 41% to $183 million. Enovix operates in the advanced lithium-ion battery manufacturing industry, specializing in silicon-anode architectures for consumer electronics and industrial applications.
Enovix Corporation appointed Dr. Michael Vyvoda as Chief Operating Officer, effective July 29, 2026. Dr. Vyvoda previously held leadership roles at Magrathea Metals, Aircapture, and Apple Inc., where he managed product operations for AirPods. His employment agreement includes an annual base salary of $440,000 and a target annual discretionary cash bonus of 60% of his base salary. On August 5, 2026, he will be granted $4,000,000 in RSUs vesting over three years and $100,000 in immediately vested RSUs. The company operates in the battery technology industry, designing and manufacturing advanced lithium-ion batteries.